Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|December 9, 2025
[Search for risk factors for slowed intra-atrial conduction in patients with schizophrenia]S A Galkin, E G Kornetova, V F Lebedeva, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|June 5, 2026
[Predictors of life engagement in patients with schizophrenia]E G Kornetova, S A Galkin, D A Petkun, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|March 6, 2025
[PANSS six-factor model]E G Kornetova, S A Galkin, A N Kornetov, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|April 27, 2024
[Cerebral hemodynamic disorders in patients with schizophrenia with concomitant metabolic syndrome]S A Galkin, E G Kornetova, T A Oshkina, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|April 15, 2026
[Serum NOS1AP concentration: association with clinical schizophrenia polymorphism and metabolic syndrome]Y V Shternis, I A Mednova, D A Petkun, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|April 15, 2026
[Prognostic value of atherogenicity indices in schizophrenia patients with metabolic syndrome]S A Galkin, E G Kornetova, I A Mednova, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|June 17, 2024
[Electroencephalographic differences in patients with paranoid schizophrenia with or without a history of suicide attempts]S A Galkin, E G Kornetova, N N Azarenko, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|March 11, 2024
[The relationship between the functional state of the brain and clinical and constitutional factors in schizophrenia]S A Galkin, E G Kornetova, T A Oshkina, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|December 9, 2025
[Constitutional and morphological bases of suicidal behavior in patients with schizophrenia]E G Kornetova, S A Galkin, V I Gerasimova, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|February 11, 2025
[The association of NOS1AP gene polymorphisms with the duration of the QT interval in patients with schizophrenia receiving antipsychotic therapy]E G Kornetova, S A Galkin, I A Mednova, et al.
Pageof 2